BACKGROUND: The diagnostic criteria of the metabolic syndrome (MS) have been applied in studies of obese adults to estimate the metabolic risk-associated with obesity, even though no general consensus exists concerning its definition and clinical value. We reviewed the current literature on the MS, focusing on those studies that used the MS diagnostic criteria to analyze children, and we observed extreme heterogeneity for the sets of variables and cutoff values chosen. OBJECTIVES: To discuss concerns regarding the use of the existing definition of the MS (as defined in adults) in children and adolescents, analyzing the scientific evidence needed to detect a clustering of cardiovascular risk-factors. Finally, we propose a new methodological approach for estimating metabolic risk-factor clustering in children and adolescents. RESULTS: Major concerns were the lack of information on the background derived from a child's family and personal history; the lack of consensus on insulin levels, lipid parameters, markers of inflammation or steato-hepatitis; the lack of an additive relevant effect of the MS definition to obesity per se. We propose the adoption of 10 evidence-based items from which to quantify metabolic risk-factor clustering, collected in a multilevel Metabolic Individual Risk-factor And CLustering Estimation (MIRACLE) approach, and thus avoiding the use of the current MS term in children. CONCLUSION: Pediatricians should consider a novel and specific approach to assessing children/adolescents and should not simply derive or adapt definitions from adults. Evaluation of insulin and lipid levels should be included only when specific references for the relation of age, gender, pubertal status and ethnic origin to health risk become available. This new approach could be useful for improving the overall quality of patient evaluation and for optimizing the use of the limited resources available facing to the obesity epidemic.
BACKGROUND: The diagnostic criteria of the metabolic syndrome (MS) have been applied in studies of obese adults to estimate the metabolic risk-associated with obesity, even though no general consensus exists concerning its definition and clinical value. We reviewed the current literature on the MS, focusing on those studies that used the MS diagnostic criteria to analyze children, and we observed extreme heterogeneity for the sets of variables and cutoff values chosen. OBJECTIVES: To discuss concerns regarding the use of the existing definition of the MS (as defined in adults) in children and adolescents, analyzing the scientific evidence needed to detect a clustering of cardiovascular risk-factors. Finally, we propose a new methodological approach for estimating metabolic risk-factor clustering in children and adolescents. RESULTS: Major concerns were the lack of information on the background derived from a child's family and personal history; the lack of consensus on insulin levels, lipid parameters, markers of inflammation or steato-hepatitis; the lack of an additive relevant effect of the MS definition to obesity per se. We propose the adoption of 10 evidence-based items from which to quantify metabolic risk-factor clustering, collected in a multilevel Metabolic Individual Risk-factor And CLustering Estimation (MIRACLE) approach, and thus avoiding the use of the current MS term in children. CONCLUSION: Pediatricians should consider a novel and specific approach to assessing children/adolescents and should not simply derive or adapt definitions from adults. Evaluation of insulin and lipid levels should be included only when specific references for the relation of age, gender, pubertal status and ethnic origin to health risk become available. This new approach could be useful for improving the overall quality of patient evaluation and for optimizing the use of the limited resources available facing to the obesity epidemic.
Authors: Costan G Magnussen; Juha Koskinen; Wei Chen; Russell Thomson; Michael D Schmidt; Sathanur R Srinivasan; Mika Kivimäki; Noora Mattsson; Mika Kähönen; Tomi Laitinen; Leena Taittonen; Tapani Rönnemaa; Jorma S A Viikari; Gerald S Berenson; Markus Juonala; Olli T Raitakari Journal: Circulation Date: 2010-10-04 Impact factor: 29.690
Authors: Aaron S Kelly; Julia Steinberger; David R Jacobs; Ching-Ping Hong; Antoinette Moran; Alan R Sinaiko Journal: Int J Pediatr Obes Date: 2010-11-11
Authors: Manpreet K Singh; Sara M Leslie; Mary Melissa Packer; Yevgeniya V Zaiko; Owen R Phillips; Elizabeth F Weisman; Danielle M Wall; Booil Jo; Natalie Rasgon Journal: Horm Behav Date: 2018-04-23 Impact factor: 3.587
Authors: Anna Viitasalo; Timo A Lakka; David E Laaksonen; Kai Savonen; Hanna-Maaria Lakka; Maija Hassinen; Pirjo Komulainen; Tuomo Tompuri; Sudhir Kurl; Jari A Laukkanen; Rainer Rauramaa Journal: Diabetologia Date: 2014-01-24 Impact factor: 10.122
Authors: Ana Elisa M Rinaldi; Gustavo D Pimentel; Avany F Pereira; Gleice Fcp Gabriel; Fernando Moreto; Roberto C Burini Journal: Diabetol Metab Syndr Date: 2010-06-09 Impact factor: 3.320
Authors: Laura Pulkki-Råback; Marko Elovainio; Mika Kivimäki; Noora Mattsson; Olli T Raitakari; Sampsa Puttonen; Jukka Marniemi; Jorma S A Viikari; Liisa Keltikangas-Järvinen Journal: Health Psychol Date: 2009-01 Impact factor: 4.267
Authors: Tanya Halvorsen; Antoinette Moran; David R Jacobs; Lyn M Steffen; Alan R Sinaiko; Xia Zhou; Julia Steinberger Journal: J Pediatr Date: 2015-08-22 Impact factor: 4.406